- Home
- NMT vs XTNT Comparison
NMT vs XTNT Comparison
Compare NMT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMT
- XTNT
- Stock Information
- Founded
- NMT 1993
- XTNT N/A
- Country
- NMT United States
- XTNT United States
- Employees
- NMT N/A
- XTNT N/A
- Industry
- NMT Finance/Investors Services
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMT Finance
- XTNT Health Care
- Exchange
- NMT Nasdaq
- XTNT Nasdaq
- Market Cap
- NMT 107.8M
- XTNT 112.1M
- IPO Year
- NMT N/A
- XTNT N/A
- Fundamental
- Price
- NMT $11.47
- XTNT $0.80
- Analyst Decision
- NMT
- XTNT
- Analyst Count
- NMT 0
- XTNT 0
- Target Price
- NMT N/A
- XTNT N/A
- AVG Volume (30 Days)
- NMT 19.1K
- XTNT 395.2K
- Earning Date
- NMT 01-01-0001
- XTNT 11-11-2025
- Dividend Yield
- NMT 3.21%
- XTNT N/A
- EPS Growth
- NMT N/A
- XTNT N/A
- EPS
- NMT N/A
- XTNT N/A
- Revenue
- NMT N/A
- XTNT $127,766,000.00
- Revenue This Year
- NMT N/A
- XTNT $13.03
- Revenue Next Year
- NMT N/A
- XTNT N/A
- P/E Ratio
- NMT N/A
- XTNT N/A
- Revenue Growth
- NMT N/A
- XTNT 15.16
- 52 Week Low
- NMT $9.05
- XTNT $0.33
- 52 Week High
- NMT $10.93
- XTNT $0.95
- Technical
- Relative Strength Index (RSI)
- NMT 42.08
- XTNT 50.78
- Support Level
- NMT $11.42
- XTNT $0.75
- Resistance Level
- NMT $11.60
- XTNT $0.95
- Average True Range (ATR)
- NMT 0.09
- XTNT 0.08
- MACD
- NMT -0.01
- XTNT -0.01
- Stochastic Oscillator
- NMT 23.68
- XTNT 22.93
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.